# FDA Inspection 1024370 - Onelegacy - August 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/onelegacy/9ad2d98a-808e-49da-a5be-eb29ad9a8d6c
Source feed: FDA_Inspections

> FDA Inspection 1024370 for Onelegacy on August 23, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1024370
- Company Name: Onelegacy
- Inspection Date: 2017-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 915574 - 2015-02-19](https://www.keypedia.com/records/fda_inspections/onelegacy/18afb123-98ac-4023-aa93-4b415495ae25)
- [FDA Inspection 787867 - 2012-06-15](https://www.keypedia.com/records/fda_inspections/onelegacy/52b998a6-ff47-4137-b8e6-b3e60b99f5ef)

Company: https://www.keypedia.com/companies/onelegacy/0a6a2db7-07dd-4a7a-b1ab-2a3ed379990d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d